ÂÜÀòÂÒÂ×

Guillaume Gerard, MSc, eMBA, currently serves as Global Head of Engineering at Corden Pharma, overseeing capital expenditure management exceeding 200 million euros across 11 sites. Previous experience includes founding SEA Pharmaceuticals GmbH, where strategic advisory services in M&A and operational strategy were provided, and serving as General Manager at Eumedica Pharmaceuticals AG, directing a Swiss entity with marketing authorizations for 15 products. Guillaume held the position of Strategy & KPI Director at Takeda, focusing on continuous improvement and digital transformation, and has been involved in significant roles at F.Hoffmann-La Roche Ltd, Sandoz, Novartis, Syngenta, and Schwarzkopf & Henkel, contributing to drug delivery systems, quality management, and packaging development. Academic qualifications include an International Executive MBA from the University of St.Gallen and a Master Engineer Degree in Material Science and Process Engineering from École supérieure d'ingénieurs de Reims.